These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5423075)

  • 21. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on pH-sensitive micellar structures for sustained drug delivery: experiments and computer simulations.
    Guo XD; Zhang LJ; Wu ZM; Qian Y
    J Control Release; 2011 Nov; 152 Suppl 1():e26-8. PubMed ID: 22195898
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
    Cai J; Zhang Y; Du W; Nan K
    J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of critical manufacturing and formulation variables for a hydrophilic matrix tablet formulation using an in vitro discriminatory dissolution method.
    Stark P; Kinahan A; Cunningham S; Butler J; O'Hara T; Dunne A; Connolly J; Devane J
    Adv Exp Med Biol; 1997; 423():137-47. PubMed ID: 9269489
    [No Abstract]   [Full Text] [Related]  

  • 26. Preparation, characterisation and antibacterial activity of a florfenicol-loaded solid lipid nanoparticle suspension.
    Wang T; Chen X; Lu M; Li X; Zhou W
    IET Nanobiotechnol; 2015 Dec; 9(6):355-61. PubMed ID: 26647811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IVIVC of controlled release formulations: physiological-dynamical reasons for their failure.
    Dokoumetzidis A; Macheras P
    J Control Release; 2008 Jul; 129(2):76-8. PubMed ID: 18538435
    [No Abstract]   [Full Text] [Related]  

  • 28. [Application and theoretical development of pharmaceutical forms for controlled liberation using methacrylic films. Preliminary communication. Fabrication and evaluation of free film plans].
    Gurny R; Mordier D; Buri P
    Pharm Acta Helv; 1976; 51(12):384-90. PubMed ID: 1023228
    [No Abstract]   [Full Text] [Related]  

  • 29. Basics of Compounding: Hot Melt Extrusion.
    DePasquale S
    Int J Pharm Compd; 2017; 21(6):471-479. PubMed ID: 29220337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing.
    Bianchini R; Vecchio C
    Farmaco; 1989 Jun; 44(6):645-54. PubMed ID: 2803450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
    Hamza Yel-S; Aburahma MH
    Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of an extemporaneous liquid formulation of lisinopril.
    Thompson KC; Zhao Z; Mazakas JM; Beasley CA; Reed RA; Moser CL
    Am J Health Syst Pharm; 2003 Jan; 60(1):69-74. PubMed ID: 12533979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of Metronidazole Suspensions.
    Donnelly RF; Ying J
    Int J Pharm Compd; 2015; 19(3):248-51. PubMed ID: 26714365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomineralized hydrophobically modified alginate membrane for sustained drug delivery.
    Sun X; Shi J; Zhang Z; Cao S
    J Control Release; 2011 Nov; 152 Suppl 1():e79-81. PubMed ID: 22195942
    [No Abstract]   [Full Text] [Related]  

  • 36. A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale.
    Xu X; Khan MA; Burgess DJ
    Int J Pharm; 2012 Feb; 423(2):543-53. PubMed ID: 22155413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets.
    Meyyanathan SN; Rajan S; Muralidaharan S; Siddaiah MK; Krishnaraj K; Suresh B
    Drug Deliv; 2008 Sep; 15(7):429-35. PubMed ID: 18712620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in pharmaceutical technology during 1970 and 1971].
    Chalabala M; Heliová M; Lichnerová I; Rak J; Malý J; Slaný J; Starha J
    Cesk Farm; 1972 Nov; 21(9):411-31. PubMed ID: 4575871
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigation on the preparation and application of chitosan/alginate microcapsules.
    Yang D; Guo S; Qiao J; Nie J
    J Control Release; 2011 Nov; 152 Suppl 1():e71-2. PubMed ID: 22195936
    [No Abstract]   [Full Text] [Related]  

  • 40. Stability of refrigerated miglustat after preparation in InOrpha(®) flavored suspending excipient for compounding of oral solutions and suspensions.
    Riahi S; Ambühl M; Stichler J; Bandilla D
    Drug Des Devel Ther; 2015; 9():561-6. PubMed ID: 25632223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.